A Novel Variant in the WRN Gene Detected in a Case of Early-Onset Severe Insulin Resistance Displaying Some but Not All Hallmarks of Progeroid Werner Syndrome
Diabetes Care · 2024
DOI: 10.2337/dc23-1479 ↗Kurz gefasst
Fallbericht in der Zeitschrift Diabetes Care, 2024. Verfasst von Dominik Spira und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu…. Hauptthemen laut MEDLINE: Werner Syndrome, Insulin Resistance. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE Determining the cause of severe insulin resistance and early-onset diabetes in the case of a young woman in which a wide range of differential diagnoses did not apply. RESEARCH DESIGN AND METHODS Diagnostic workup including medical history, physical examination, specialist consultations, imaging methods, laboratory assessment, and genetic testing carried out by next-generation panel sequencing. RESULTS After ruling out several differential diagnoses, genetic testing revealed a previously unknown homozygous variant within the canonical splice site of intron 4 in the WRN gene classified as pathogenic. Thus, although not all cardinal clinical criteria according to existing guidelines had been met, the phenotype of our patient was attributed to Werner syndrome (WS), an autosomal-recessive inherited progeroid syndrome. CONCLUSIONS WS, although rare, must be considered as a differential diagnosis in cases of severe insulin resistance. Moreover, recognized clinical criteria of WS may not lead to diagnosis in all cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
- Labor Berlin-Charité Vivantes GmbH, Humangenetik/Next Generation Sequencing, Berlin, Germany.
- Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Lipidclinic Universitätsmedizin Rostock, Rostock, Germany.
- European Reference Network on Rare Endocrine Conditions, Reference Centre, Charité Universitätsmedizin Berlin, Berlin, Germany.
ORCID-Profile: Dominik Spira, Ilja Demuth, Lukas Maurer, Knut Mai, Joachim Spranger
Zitieren
APA
Spira, D., Herbst, S., Schwartzmann, S., Dutrannoy, V., Steinhagen-Thiessen, E., Demuth, I., Maurer, L., Mai, K., Spranger, J., Mundlos, S., & Bobbert, T. (2024). A Novel Variant in the WRN Gene Detected in a Case of Early-Onset Severe Insulin Resistance Displaying Some but Not All Hallmarks of Progeroid Werner Syndrome. Diabetes Care. https://doi.org/10.2337/dc23-1479
Vancouver
Spira D, Herbst S, Schwartzmann S, Dutrannoy V, Steinhagen-Thiessen E, Demuth I, et al. A Novel Variant in the WRN Gene Detected in a Case of Early-Onset Severe Insulin Resistance Displaying Some but Not All Hallmarks of Progeroid Werner Syndrome. Diabetes Care. 2024. doi:10.2337/dc23-1479
BibTeX
@article{Spira2024,
author = {Spira, Dominik and Herbst, Susanne and Schwartzmann, Sarina and Dutrannoy, Véronique and Steinhagen-Thiessen, Elisabeth and Demuth, Ilja and Maurer, Lukas and Mai, Knut and Spranger, Joachim and Mundlos, Stefan and Bobbert, Thomas},
title = {A Novel Variant in the WRN Gene Detected in a Case of Early-Onset Severe Insulin Resistance Displaying Some but Not All Hallmarks of Progeroid Werner Syndrome},
journal = {Diabetes Care},
year = {2024},
doi = {10.2337/dc23-1479}
}
EUVIMED